Scaleup
CorFlow Therapeutics completes €44 Million Series B
The new funds supports the advancement of a diagnostic and drug delivery platform for microvascular obstruction in heart attack patients
The new funds supports the advancement of a diagnostic and drug delivery platform for microvascular obstruction in heart attack patients